Progenics Pharmaceuticals (PGNX)

Create an Alert
4.805 +0.04  +0.95%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD

Progenics Pharmaceuticals Cash from Investing Quarterly:

2.039M for March 31, 2013
View Full Chart

Progenics Pharmaceuticals Cash from Investing Quarterly Chart

    Progenics Pharmaceuticals Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 2.039M
    Dec. 31, 2012 0.014M
    Sept. 30, 2012 0.077M
    June 30, 2012 -0.074M
    March 31, 2012 -0.294M
    Dec. 31, 2011 0.016M
    Sept. 30, 2011 0.05M
    June 30, 2011 0.037M
    March 31, 2011 -0.029M
    Dec. 31, 2010 -0.044M
    Sept. 30, 2010 -0.843M
    June 30, 2010 -1.272M
    March 31, 2010 1.688M
    Dec. 31, 2009 0.085M
    Sept. 30, 2009 17.53M
    June 30, 2009 42.87M
    March 31, 2009 19.16M
    Dec. 31, 2008 30.57M
    Sept. 30, 2008 -2.659M
    June 30, 2008 11.99M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    PGNX Cash from Investing Quarterly Benchmarks

    Companies
    Santarus -1.594M
    Salix Pharmaceuticals -1.211M
    Jazz Pharmaceuticals -2.443M

    PGNX Cash from Investing Quarterly Rankings

    Overall 94th percentile
    851 of 16773
    Sector 93rd percentile
    93 of 1408 in Healthcare
    Industry 88th percentile
    53 of 453 in Biotechnology

    PGNX Cash from Investing Quarterly Range, Past 5 Years

    Minimum -2.659M Sep 2008
    Maximum 42.87M Jun 2009
    Average 6.046M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');